Craig Fraser - 29 Jun 2022 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role
President and CEO, Director
Signature
/s/ John P. Hamill, as Attorney-in-Fact
Issuer symbol
WINT
Transactions as of
29 Jun 2022
Net transactions value
+$2,908
Form type
4
Filing time
30 Jun 2022, 06:59:36 UTC
Previous filing
17 Mar 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WINT Common Stock Purchase $2,908 +7,000 +3.3% $0.4154 217,058 29 Jun 2022 Direct F1
holding WINT Common Stock 147 29 Jun 2022 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple trades at prices ranging from $0.4115 to $0.4200. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.